University of Porto at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

University of Porto brings 2 presentations to ENA 2026 in Barcelona. Its program centres on BBIT20, a first-in-class disruptor of the BRCA1-BARD1 interaction. The work shows BBIT20 overcoming multidrug resistance in ovarian cancer and boosting anti-PD-1 efficacy in pancreatic cancer by reshaping the tumor immune landscape.

OrganizationENA 2026 Attendance
University of Porto
Porto, Portugal
up.pt
Universities & institutes
Public university in Portugal whose faculties of pharmacy and medicine and its i3S institute run cancer research.
Talk
Fri Nov 20
3:15–3:25pm
Poster
Fri Nov 20
10:45–11:15am
1:30–3pm

Explore the full ENA 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Barcelona. Leave your work email and we’ll be in touch.

Privacy

Download the full ENA 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of Porto

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction